Surface immunoglobulin-deficient in the peripheral blood Epstein-Barr virus-infected B cells of pediatric solid-organ transplant recipients

被引:14
作者
Schauer, E
Webber, S
Green, M
Rowe, D
机构
[1] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15213 USA
[2] Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15213 USA
[3] Childrens Hosp Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA
关键词
D O I
10.1128/JCM.42.12.5802-5810.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Epstein-Barr virus (EBV), a ubiquitous human herpesvirus, normally causes an asymptomatic latent infection with very low levels of circulating virus in the peripheral blood of infected individuals. However, EBV does have pathogenic potential and has been linked to several diseases, including posttransplant lymphoproliferative disease (PTLD), which involves very high circulating viral loads. As a consequence of immunosuppression associated with transplantation, children in particular are at risk for PTLD. Even in the absence of symptoms of PTLD, very high viral loads are often observed in these patients. EBV-infected B cells in the circulations of 16 asymptomatic pediatric solid-organ transplant recipients from Children's Hospital of Pittsburgh were simultaneously characterized for their surface immunoglobulin (sIg) isotypes and EBV genome copy numbers. Patients were characterized as having high and low viral loads on the basis of their stable levels of circulating virus. Patients with high viral loads had both high- and low-copy-number cells. Cells with a high numbers of viral episomes (20/cell) were predominantly Ig null, and cells with low numbers of episomes were predominantly sIgM positive. Patients with low viral loads carried the vast majority of their viral load in low-copy-number cells, which were predominantly IgM positive. The very rare high-copy-number cells detected in carriers with low viral loads were also predominantly Ig-null cells. This suggests that two distinct types of B-lineage cells contribute to the viral load in transplant recipients, with cells bearing high genome copy numbers having an aberrant Ig-null cellular phenotype.
引用
收藏
页码:5802 / 5810
页数:9
相关论文
共 38 条
[1]   Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients [J].
Babcock, GJ ;
Decker, LL ;
Freeman, RB ;
Thorley-Lawson, DA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (04) :567-576
[2]   EBV persistence in memory B cells in vivo [J].
Babcock, GJ ;
Decker, LL ;
Volk, M ;
Thorley-Lawson, DA .
IMMUNITY, 1998, 9 (03) :395-404
[3]   Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes [J].
Bräuninger, A ;
Spieker, T ;
Mottok, A ;
Baur, AS ;
Kuppers, R ;
Hansmann, ML .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (06) :1593-1602
[4]   Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) Epstein-Barr virus-infected B cells in angioimmunoblastic T cell lymphoma [J].
Bräuninger, A ;
Spieker, T ;
Willenbrock, K ;
Gaulard, P ;
Wacker, HH ;
Rajewsky, K ;
Hansmann, ML ;
Küppers, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (07) :927-940
[5]   Clinical usefulness of Epstein-Barr viral load in solid-organ transplantation [J].
Buteau, C ;
Paya, CV .
LIVER TRANSPLANTATION, 2001, 7 (02) :157-159
[6]   Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals [J].
Decker, LL ;
Klaman, LD ;
ThorleyLawson, DA .
JOURNAL OF VIROLOGY, 1996, 70 (05) :3286-3289
[7]   Epstein-Barr virus infections in children after transplantation of the small intestine [J].
Finn, L ;
Reyes, J ;
Bueno, J ;
Yunis, E .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (03) :299-309
[8]  
Green M, 1999, Pediatr Transplant, V3, P271, DOI 10.1034/j.1399-3046.1999.00066.x
[9]   Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease [J].
Green, M ;
Cacciarelli, TV ;
Mazariegos, GV ;
Sigurdsson, L ;
Qu, L ;
Rowe, DT ;
Reyes, J .
TRANSPLANTATION, 1998, 66 (12) :1641-1644
[10]  
GREEN M, 1999, CURR OPIN ORGAN TRAN, V4, P292